Handelnine Global LLC Recalls Rheumacare Capsules Due to Lead Contamination

What Happened

Handelnine Global LLC, based in South Plainfield, New Jersey, has initiated a voluntary recall of Rheumacare capsules. The recall was triggered by Current Good Manufacturing Practice (CGMP) deviations after the product was found to contain lead. The FDA has classified this as a Class I recall, the most serious category of recall.

Which Products Are Affected

The recall involves Rheumacare capsules packaged in 30-count bottles. The product was manufactured in India by Virgo UAP Pharma Pvt. Ltd. and distributed to a single customer in New York.

Product Details:

• Product Name: Rheumacare capsules
• UPC: 8 904218 700313
• Lot Numbers:
  • Lot: CAM040 (Expiration: 06/30/2029)
  • Lot: CAL079-N (Expiration: 09/30/2028)
• Quantity: 4 bottles
• Recall Number: D-0332-2026

What You Should Do

Consumers who have purchased the affected Rheumacare capsules should stop using the product immediately. The recalling firm, Handelnine Global LLC, is located at 4300 S Clinton Ave, South Plainfield, NJ 07080. While the distribution was limited to one customer in New York, anyone with these specific lot numbers should follow the instructions provided in the firm’s press release regarding returns or disposal.

Why This Matters

This recall is significant due to the presence of lead, a heavy metal that can cause serious health issues and toxicity. A Class I classification indicates that there is a reasonable probability that the use of or exposure to the product will cause serious adverse health consequences or death.

Source

Information provided by the FDA under recall event ID 98165.